Home / PCK1 Knockout Cell Lines

PCK1 Knockout Cell Lines

Gene: PCK1

Official Full Name: phosphoenolpyruvate carboxykinase 1provided by HGNC

Gene Summary: This gene is a main control point for the regulation of gluconeogenesis. The cytosolic enzyme encoded by this gene, along with GTP, catalyzes the formation of phosphoenolpyruvate from oxaloacetate, with the release of carbon dioxide and GDP. The expression of this gene can be regulated by insulin, glucocorticoids, glucagon, cAMP, and diet. Defects in this gene are a cause of cytosolic phosphoenolpyruvate carboxykinase deficiency. A mitochondrial isozyme of the encoded protein also has been characterized. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00876 PCK1 Knockout cell line(Hep G2) Human PCK1 1:2~1:4 Negative Online Inquiry

Background

PCK1 Gene Knockout Cell Lines are specialized genetic models designed to study the role of the phosphoenolpyruvate carboxykinase 1 (PCK1) gene in cellular metabolism and function. These cell lines are engineered using advanced CRISPR/Cas9 technology to specifically disrupt the PCK1 gene, allowing researchers to investigate the downstream effects of its loss on gluconeogenesis and other metabolic pathways.

The key function of PCK1 is to convert oxaloacetate to phosphoenolpyruvate, a critical step in the gluconeogenesis pathway. By knocking out this gene, scientists can discern how its absence impacts energy production, metabolic regulation, and overall cellular health. This has significant implications for understanding various metabolic disorders, including diabetes and obesity, where gluconeogenesis plays a crucial role in maintaining blood glucose levels.

The scientific importance of PCK1 Gene Knockout Cell Lines extends to both research and clinical applications. In research, they serve as vital tools for elucidating the mechanisms of metabolic regulation, enabling the development of therapeutic strategies targeting metabolic diseases. Clinically, insights gained from these models can lead to novel approaches in treating conditions arising from dysregulated glucose metabolism.

What sets our PCK1 Gene Knockout Cell Lines apart from alternative products is their high specificity and reliability. These cell lines are thoroughly validated for consistent knockout efficiency, ensuring reproducible results in experiments. Additionally, they are adaptable for various applications, including drug testing, genetic screening, and biomarker discovery, making them an ideal choice for diverse research needs.

Researchers and clinicians will find value in these knockout cell lines due to their potential to accelerate studies into metabolic regulations and disease mechanisms. With the growing need for innovative solutions in metabolic research, PCK1 Gene Knockout Cell Lines represent a critical advancement.

Our company prides itself on providing high-quality biological products backed by rigorous scientific research and expertise. We are dedicated to supporting the life sciences community with tools that facilitate groundbreaking discoveries and enhanced understanding of complex biological systems.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.